REFERENCES
- Roberts JM, Cooper DW, Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357:53–56.
- Gilbert JS, Ryan MJ, Lamarca BB, Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008; 294:H541–H550.
- Xia Y, Ramin SM, Kellems RE. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 2007; 50:269–275.
- Dizon-Townson D, Miller C, Sibai B, The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005; 106:517–524.
- Schjetlein R, Haugen G, Wisloff F. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstet Gynecol Scand 1997; 76:541–546.
- Holthe MR, Staff AC, Berge LN, Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynecol 2004; 190:1128–1134.
- Oron G, Ben-Haroush A, Hod M, Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia. Obstet Gynecol 2006; 107:896–900.
- Teng YC, Lin QD, Lin JH, Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J Perinat Med 2009; 37:343–348.
- Manco-Johnson MJ. Development of hemostasis in the fetus. Thromb Res 2005; 115(Suppl 1):55–63.
- Hyytiainen S, Wartiovaara-Kautto U, Ulander VM, The procoagulant effects of factor V Leiden may be balanced against decreased levels of factor V and do not reflect in vivo thrombin formation in newborns. Thromb Haemost 2006; 95:434–440.
- Edstrom CS, Calhoun DA, Christensen RD, Expression of tissue factor pathway inhibitor in human fetal and placental tissues. Early Hum Dev 2000; 59:77–84.
- Tay SP, Cheong SK, Boo NY, Circulating tissue factor, tissue factor pathway inhibitor and D-dimer in umbilical cord blood of normal term neonates and adult plasma. Blood Coagul Fibrinolysis 2003; 14:125–129.
- Zanardo V, Savio V, Sabrina G, The effect of pre-eclampsia on the levels of coagulation and fibrinolysis factors in umbilical cord blood of newborns. Blood Coagul Fibrinolysis 2005; 16:177–181.
- Zhang B. the application card of neonatal birthweight in different gestation age from fifteen cities of china. Chin J Pediatrics 1989; 27:318.
- Mello G, Parretti E, Marozio L, Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 2005; 46:1270–1274.
- Yin KH, Koh SC, Malcus P, Preeclampsia: haemostatic status and the short-term effects of methyldopa and isradipine therapy. J Obstet Gynaecol Res 1998; 24:231–238.
- Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2007; 27:1687–1693.
- Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 2006; 113:722–731.
- Lopez-Ramirez Y, Carvajal Z, Arocha-Pinango CL. [Hemostatic system parameters of placental extracts in normal pregnancy and severe preeclampsia]. Invest Clin 2006; 47:233–240.
- Bellart J, Gilabert R, Angles A, Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol 1999; 106:594–597.
- Estelles A, Gilabert J, Grancha S, Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost 1998; 79:500–508.
- Dechend R, Homuth V, Wallukat G, AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 2000; 101:2382–2387.
- Lockwood CJ, Krikun G, Caze R, Decidual cell-expressed tissue factor in human pregnancy and its involvement in hemostasis and preeclampsia-related angiogenesis. Ann N Y Acad Sci 2008; 1127:67–72.
- Atamer Y, Kocyigit Y, Yokus B, Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 119:60–66.
- Cvirn G, Gruber HJ, Koestenberger M, High availability of intravascular tissue factor in neonates. J Pediatr Hematol Oncol 2007; 29:279–283.
- Nelson KB, Thrombophilias, perinatal stroke, and cerebral palsy. Clin Obstet Gynecol 2006; 49:875–884.
- Tanjung MT, Siddik HD, Hariman H, Coagulation and fibrinolysis in preeclampsia and neonates. Clin Appl Thromb Hemost 2005; 11:467–473.
- Franchi F, Cetin I, Todros T, Intrauterine growth restriction and genetic predisposition to thrombophilia. Haematologica 2004; 89:444–449.
- Schjetlein R, Abdelnoor M, Haugen G, Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Gynecol Scand 1999; 78:191–197.
- Krikun G, Huang ST, Schatz F, Thrombin activation of endometrial endothelial cells: a possible role in intrauterine growth restriction. Thromb Haemost 2007; 97:245–253.
- Di Paolo S, Volpe P, Grandaliano G, Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. J Nephrol 2003; 16:650–657.
- Lee J, Croen LA, Backstrand KH, Maternal and infant characteristics associated with perinatal arterial stroke in the infant. JAMA 2005; 293:723–729.
- Wu YW, March WM, Croen LA, Perinatal stroke in children with motor impairment: a population-based study. Pediatrics 2004; 114:612–619.